Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Prevnar 13
Prevnar 13 Image

Prevnar 13

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Prevnar 13?

Prevnar 13, also known as pneumococcal 13-valent conjugate vaccine, is a vaccine that is specifically developed to protect against pneumococcal bacterial infections. It is approved by the Food and Drug Administration (FDA) for use in both adults and children. Pneumococcal infections are caused by the bacterium Streptococcus pneumoniae and can lead to various illnesses, such as pneumonia, meningitis, and bloodstream infections. Prevnar 13 targets 13 strains of the pneumococcal bacteria, which are known to be the most common and virulent strains that cause these infections. The vaccine works by stimulating the immune system to produce antibodies against the pneumococcal bacteria. This helps the body recognize and fight the bacteria if it is encountered in the future. It is recommended for infants, children, and adults who are at increased risk of pneumococcal infections, such as those with weakened immune systems, chronic medical conditions, or who are older adults. It's important to note that Prevnar 13 is not a substitute for routine immunizations, and it does not protect against all strains of pneumococcal bacteria. Other preventive measures, such as good hygiene practices and avoiding close contact with individuals who are sick, should still be followed.

How to use Prevnar 13?

To use Prevnar 13, follow the instructions provided by your healthcare provider. This vaccine is administered as an injection, usually into the muscle of the upper arm or thigh. It is typically given as a series of doses, depending on your age and medical history. For children, the vaccination schedule usually consists of four doses given at 2, 4, 6, and 12-15 months of age. For adults and older children who have not received the vaccine previously, a single dose may be recommended. People with certain medical conditions or who are at increased risk may require additional doses. It's important to receive the full recommended series of Prevnar 13 for optimal protection against pneumococcal bacterial infections. This vaccine helps to prevent diseases such as pneumonia, meningitis, and sepsis caused by various strains of the pneumococcal bacteria. Remember to consult with your healthcare provider for specific instructions regarding the use of Prevnar 13 and to address any concerns or questions you may have.

There are several warnings associated with the use of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) that users should be aware of: 1. Allergy: Individuals who have had a severe allergic reaction to any component of Prevnar 13, including diphtheria toxoid, should not receive this vaccine. 2. Fever: Fever may occur after vaccination with Prevnar 13. It is advisable to talk to a healthcare professional about managing fever in case it occurs. 3. Guillain-Barré Syndrome (GBS): In rare cases, GBS, a rare neurological disorder, has been reported following administration of vaccines containing similar antigens. If an individual has a history of GBS or there are concerns, it is important to discuss the situation with a healthcare provider. 4. Contraindications: Prevnar 13 should not be given to individuals who have a severe allergic reaction to any component of the vaccine or had a life-threatening reaction to a previous dose of Prevnar 13 or any other pneumococcal vaccine. As always, it is important to consult with a healthcare professional to fully understand the warnings and contraindications of any medication or vaccine, including Prevnar 13. Your healthcare provider can provide personalized advice and address any specific concerns you may have.

Before taking Prevnar 13, there are several warnings and precautions that you should be aware of. It's important to discuss these with your healthcare provider before receiving the vaccine. Here are some key points to consider: 1. Allergies: Inform your healthcare provider if you have a known allergy to any ingredients in Prevnar 13 or any previous vaccines. This includes allergies to diphtheria toxoids, inactivated poliovirus, or any other vaccine components. Allergic reactions to vaccines are rare but can occur. 2. Previous Serious Reaction: If you or your child has experienced a severe allergic reaction or any other significant side effects after receiving a pneumococcal or any other vaccine, it's crucial to inform your healthcare provider. They will assess the risk versus benefit of giving the vaccine in such cases. 3. Fever or Illness: If you or your child currently has a moderate to severe fever or an acute illness, it's generally advisable to postpone receiving the vaccine until you or the child have recovered. This is because fever or illness can potentially interfere with the body's response to the vaccine. 4. Bleeding Disorders: Individuals with bleeding disorders or those who are receiving blood-thinning medications may need special precautions when receiving the vaccine. This is to minimize the risk of bleeding at the injection site. Inform your healthcare provider if you have any bleeding disorders or are taking blood-thinning medications. 5. Immunocompromised Individuals: If you or your child have a weakened immune system due to certain medical conditions, medications, or treatments such as chemotherapy, it's important to discuss the potential benefits and risks of the vaccine with your healthcare provider. While Prevnar 13 is generally safe, it may have a reduced effectiveness in individuals with compromised immune systems. 6. Pregnant or breastfeeding: If you are pregnant or breastfeeding, it's important to discuss the risks and benefits of receiving the vaccine with your healthcare provider. Generally, Prevnar 13 is not routinely given during pregnancy unless the potential benefits outweigh the risks. Remember, these are just some general warnings and precautions. It's always best to consult with your healthcare provider who can provide personalized advice based on your individual medical history.

Prevnar 13 is a vaccine that helps protect against pneumococcal bacterial infections. It is primarily given to infants, children, and adults who are at higher risk of developing these infections, such as older adults and individuals with certain medical conditions. Like any vaccine, Prevnar 13 can cause side effects, although not everyone experiences them. Common side effects may include redness, swelling, or pain at the injection site. Some individuals may also experience fever, irritability, drowsiness, or loss of appetite. These side effects are generally mild and temporary. In rare cases, more serious side effects may occur. These can include severe allergic reactions, such as difficulty breathing, hives, or swelling of the face and throat. It is important to seek immediate medical attention if any severe or unusual reactions occur after receiving the vaccine. Although side effects are possible, it is important to weigh the risks versus the benefits. Prevnar 13 has been proven to be highly effective in preventing pneumococcal infections, which can cause pneumonia, meningitis, and other serious illnesses. It is always recommended to consult with a healthcare professional for personalized advice and guidance regarding vaccination.

The active ingredients in Prevnar 13 are a mixture of capsular polysaccharides derived from 13 different types of Streptococcus pneumoniae bacteria. These bacteria can cause serious infections such as pneumonia, meningitis, and bacteremia. Each dose of Prevnar 13 contains a purified extract of the polysaccharides from the following 13 pneumococcal bacteria serotypes: 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F. These polysaccharides are conjugated to a carrier protein called CRM197, derived from a non-toxic strain of diphtheria toxin. This conjugation process enhances the immune response to the polysaccharides and helps to stimulate the production of protective antibodies. Other ingredients present in Prevnar 13 include saline solution, sucrose, aluminum phosphate, and polysorbate 80. These ingredients help to stabilize the vaccine and ensure its effectiveness. It's important to note that Prevnar 13 is only available as a vaccine and should not be confused with medications or drugs used for treating bacterial infections.

Prevnar 13, the FDA-approved vaccine, is used to protect against pneumococcal bacterial infections. When it comes to storing this vaccine, it is essential to follow the recommended guidelines to maintain its potency and effectiveness. Generally, Prevnar 13 should be stored in a refrigerator between 2°C and 8°C (36°F and 46°F). It's important to keep the vaccine away from freezing temperatures, as freezing may render it ineffective. Therefore, it should never be stored in the freezer. Additionally, the vaccine should be protected from light. The original packaging should be kept intact until the time of administration to shield the vaccine from direct exposure to light. If you are unsure about the proper storage or have any concerns regarding the vaccine, it is always best to consult with your healthcare provider or pharmacist. They can provide specific instructions and address any questions you may have to ensure the vaccine is stored correctly and remains safe and effective for use.